Health
SARS-CoV-2 D614G mutation does affect performance of serological assays – News-Medical.Net
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared…
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared spike G614-based assay to the original D614-based assay – pointing towards the development of recognizable, cross-responsive humoral immunity.
The need to understand the coronavirus disease (COVID-19) pandemic caused by the SARS-CoV-2 has turned our eye towards the acquisition and development of population immunity. We know that the human…
-
General22 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General7 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General19 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News22 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’